Results 81 to 90 of about 7,815 (117)

Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis. [PDF]

Sci Transl Med
Li DJ, Berry CE, Wan DC, Longaker MT.
europepmc   +1 more source

Dermatological Manifestations in Patients With Chronic Kidney Disease: A Review. [PDF]

Cureus
Arriaga Escamilla D, Lakhani A, Antony S, Salazar Villegas KN, Gupta M, Ramnath P, Murillo Pineda MI, Bedor A, Banegas D, Calderon Martinez E.   +9 more
europepmc   +1 more source

Gadolinium-Induced Nephrogenic Systemic Fibrosis. [PDF]

Methodist Debakey Cardiovasc J, 2017
Shah AH, Olivero JJ.
europepmc   +1 more source

Nephrogenic Fibrosing Dermopathy with Osteoid Metaplasia

, 2008
V. Mathur, H.K. Park, J. Finley
core   +1 more source

Nephrogenic Fibrosing Dermopathy: Case report and review

, 2006
George, Saira J, Hsu, Sylvia, Lu, Dornechia E George Rebecca   +2 more
core   +1 more source

Nephrogenic systemic fibrosis: the end of the story? [PDF]

Quant Imaging Med Surg, 2019
Malikova H.
europepmc   +1 more source

Nephrogenic Fibrosing Dermopathy With Systemic Involvement

, 2003
Mary Seabury Stone, William W. Ting, Kathi C. Madison, Kevin Kurtz   +3 more
core   +1 more source

Gadolinium deposition in nephrogenic fibrosing dermopathy

, 2008
B.H. Thiers
core   +1 more source

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach From the Writing Committee of the American Society for Apheresis: The Tenth Special Issue. [PDF]

J Clin Apher
Zantek ND, Alquist CR, Hofmann JC, Klingel R, Levenbrown Y, Onwuemene OA, Patidar G, Patriquin CJ, Raval JS, Sanchez AP, Schneiderman J, Tanhehco YC, Connelly-Smith L.   +12 more
europepmc   +1 more source

Gadolinium-based contrast agents: why nephrologists need to be concerned. [PDF]

Curr Opin Nephrol Hypertens, 2019
Leyba K, Wagner B.
europepmc   +1 more source